A guide to developing population files for physiologically‐based pharmacokinetic modeling in the Simcyp Simulator
CPT: Pharmacometrics & Systems Pharmacology · 2024
DOI: 10.1002/psp4.13202 ↗Kurz gefasst
Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2024. Verfasst von Liam Curry und 9 weiteren Autor:innen. Beteiligte Einrichtung: Certara Predictive Technologies (CPT), Simcyp Division, Sheffield, UK. Hauptthemen laut MEDLINE: Models, Biological, Computer Simulation, Software, Pharmacokinetics. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The Simcyp Simulator is a software platform widely used in the pharmaceutical industry to conduct stochastic physiologically‐based pharmacokinetic (PBPK) modeling. This approach has the advantage of combining routinely generated in vitro data on drugs and drug products with knowledge of biology and physiology parameters to predict a priori potential pharmacokinetic changes in absorption, distribution, metabolism, and excretion for populations of interest. Combining such information with pharmacodynamic knowledge of drugs enables planning for potential dosage adjustment when clinical studies are feasible. Although the conduct of dedicated clinical studies in some patient groups (e.g., with hepatic or renal diseases) is part of the regulatory path for drug development, clinical studies for all permutations of covariates potentially affecting pharmacokinetics are impossible to perform. The role of PBPK in filling the latter gap is becoming more appreciated. This tutorial describes the different input parameters required for the creation of a virtual population giving robust predictions of likely changes in pharmacokinetics. It also highlights the considerations needed to qualify the models for such contexts of use. Two case studies showing the step‐by‐step development and application of population files for obese or morbidly obese patients and individuals with Crohn's disease are provided as the backbone of our tutorial to give some hands‐on and real‐world examples.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Certara Predictive Technologies (CPT), Simcyp Division, Sheffield, UK.
- Centre for Applied Pharmacokinetic Research (CAPKR), The University of Manchester, Manchester, UK.
- Pharmaceutical Chemistry Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
- Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University, Tanta, Egypt.
ORCID-Profile: Liam Curry, Frederic Y Bois, Eman El-Khateeb, Trevor N Johnson, Sibylle Neuhoff, Amin Rostami-Hodjegan
Zitieren
APA
Curry, L., Alrubia, S., Bois, F. Y., Clayton, R., El-Khateeb, E., Johnson, T. N., Faisal, M., Neuhoff, S., Wragg, K., & Rostami-Hodjegan, A. (2024). A guide to developing population files for physiologically‐based pharmacokinetic modeling in the Simcyp Simulator. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.13202
Vancouver
Curry L, Alrubia S, Bois FY, Clayton R, El-Khateeb E, Johnson TN, et al. A guide to developing population files for physiologically‐based pharmacokinetic modeling in the Simcyp Simulator. CPT: Pharmacometrics & Systems Pharmacology. 2024. doi:10.1002/psp4.13202
BibTeX
@article{Curry2024,
author = {Curry, Liam and Alrubia, Sarah and Bois, Frederic Y and Clayton, Ruth and El-Khateeb, Eman and Johnson, Trevor N and Faisal, Muhammad and Neuhoff, Sibylle and Wragg, Kris and Rostami-Hodjegan, Amin},
title = {A guide to developing population files for physiologically‐based pharmacokinetic modeling in the Simcyp Simulator},
journal = {CPT: Pharmacometrics & Systems Pharmacology},
year = {2024},
doi = {10.1002/psp4.13202}
}
EUVIMED